Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
The drug is priced at Rs 2000 for a course of 40 tablets
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated
The first pilot study from India analyzing Covaxin-Covishield mixed doses
The Health ID will allow users to connect with different healthcare providers and enable a consent-based sharing of personal health records
A toll-free helpline to be set up to help doctors and patients
Celltrion plans to provide dual treatment options for COVID-19; Regkirona for hospitalised patients and a nebulised cocktail therapy (CT-P63 in combination with Regkirona) for at- home settings
Subscribe To Our Newsletter & Stay Updated
